Drug information for patients - An update of long-term results: Type of enquiries and patient characteristics

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 2, 2009, Pages 111-119

  Huber, Martin ^a,b   Kullak Ublick, Gerd A ^b   Kirch, Wilhelm ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Age distribution; Drug information service; Patients; Type of enquiry

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; GASTROINTESTINAL AGENT; HOMEOPATHIC AGENT; HORMONES AND AGENTS ACTING ON THE ENDOCRINE SYSTEM; IMMUNOMODULATING AGENT; RESPIRATORY TRACT AGENT;

ACCESS TO INFORMATION; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INFORMATION; DRUG INTERACTION; DRUG UTILIZATION; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; SELF MEDICATION; SEX DIFFERENCE; SOCIAL STATUS; UNSPECIFIED SIDE EFFECT; ATTITUDE TO HEALTH; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; SOCIOECONOMICS; STATISTICS; TIME; UTILIZATION REVIEW;

ACCESS TO INFORMATION; AGED; DRUG INFORMATION SERVICES; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 62649117888     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1682     Document Type: Article

References (45)

1. WHO. Fifty-fifth World Health Assembly. Quality of care: patient safety. WHA55.18. Geneva; May 2002. http://www.who.int/gb/ebwha/pdf_files/WHA55/ ewha5518.pdf [accessed 15 May 2008].
2. Schneider PJ, Gift MG, Lee YP, Rothermich EA, Sill BE. Cost of medication-related problems at a university hospital. Am J Health Syst Pharm 1995; 52: 2415-2418.
3. Gautier S, Bachelet H, Bordet R, Caron J. The cost of adverse drug reactions. Expert Opin Pharmacother 2003; 4: 319-326.
4. Dennehy CE, Tsourounis C, Horn AJ. Dietary supplement-related adverse events reported to the California Poison Control System. Am J Health Syst Pharm 2005; 62: 1476-1482.
5. Gryzlak BM, Wallace RB, Zimmerman MB, Nisly NL. National surveillance of herbal dietary supplement exposures: the poison control center experience. Pharmacoepidemiol Drug Saf 2007; 16: 947-957.
6. Donaldson L, Philip P. Patient safety - a global priority. Bull World Health Organ 2004; 82 892.
7. Deveugele M, Derese A, van den Brink-Muinen A, Bensing J, De Maeseneer J. Consultation length in general practice: cross sectional study in six European countries. Br Med J 2002; 325: 472-474.
8. Krause P, Wittchen HU, Küpper B, et al. (Management of diabetes and hypertension: how do primary care physicians judge their performance?) German. Fortschr Med Orig 2003; 121 1: 12-18.
9. McMahon T, Clark CM, Bailie GR. Who provides patients with drug information? Br Med J (Clin Res Ed) 1987; 294: 355-356.
10. Sturdee DW. The importance of patient education in improving compliance. Climacteric 2000; 3 2: 9-13.
11. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697-704.
12. Anderson JG, Rainey MR, Eysenbach G. The impact of CyberHealthcare on the physician-patient relationship. J Med Syst 2003; 27: 67-84.
13. Ko Y, Brown M, Frost R, Woosley RL. Brief report: development of a prescription medication information webliography for consumers. J Gen Intern Med 2006; 21: 1313-1316.
14. Bader SA, Braude RM. "Patient informatics": creating new partnerships in medical decision making. Acad Med 1998; 73: 408-411.
15. Stahl C, Brauer S, Zeitler HP, Gulich M. How important is a package insert for drug therapy in ambulatory care? J Public Health 2006; 14: 174-177.
16. Little P, Everitt H,Williamson I, et al. Preferences of patients for patient centred approach to consultation in primary care: observational study. Br Med J 2001; 322: 468-472.
17. Fuchs A,Winkler U, Maywald U, KirchW. (Drug information services for physicians and patients. Acceptance and benefits) German. Internist ( Berl) 2007; 48: 1029-1035.
18. Tröger U, Meyer FP. The regional drug-therapy consultation service centre - a conception that has been serving patients and physicians alike for 30 years in Magdeburg (Germany). Eur J Clin Pharmacol 2000; 55: 707-711.
19. Bertsche T, Hämmerlein A, Schulz M. German national drug information service: user satisfaction and potential positive patient outcomes. Pharm World Sci 2007; 29: 167-172.
20. Maywald U, Schindler C, Krappweis J, KirchW. First patient-centered drug information service in Germany - a descriptive study. Ann Pharmacother 2004; 38: 2154-2159.
21. Maywald U, Schindler C, Bux Y, Kirch W. (Drug information for patients - unmet needs, evaluation and influence on the compliance), German. Dtsch Med Wochenschr 2005; 130: 1485-1490.
22. Schwarz UI, Krappweis J, Stoelben S, Kirch W. Drug information services: initial experiences in Dresden. Eur J Clin Pharmacol 1998; 54: 667-668.
23. Schwarz UI, Stoelben S, Ebert U, Siepmann M, Krappweis J, Kirch W. Regional drug information service. Int J Clin Pharmacol Ther 1999; 37: 263-268.
24. Hach I, Meusel D, Maywald U, Kirch W. (Drug information centers - instruments for health care research?) German. Med Klin (Munich) 2005; 100: 396-400.
25. Roe CM, McNamara AM, Motheral BR. Gender - and age-related prescription drug use patterns. Ann Pharmacother 2002; 36: 30-39.
26. Glaeske G, Janhsen K. (GEK Drug Report 2007) German. Asgard-Verlag: St. Augustin 2007; 104-117.
27. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-351.
28. Statistisches Landesamt des Freistaates Sachsen. (Population on 1 January 1990 and 31 December 2006 per age and gender) German. Kamenz; May 2008. http://www.statistik.sachsen.de/21/02_02/02_02_04_grafik.asp [accessed 15 May 2008].
29. Husaini BA, Moore ST, Cain VA. Psychiatric symptoms and help-seeking behavior among the elderly: an analysis of racial and gender differences. J Gerontol Soc Work 1994; 21: 177-195.
30. Smith GH, Einarson TR. Survey of consumer users of a statewide drug information service. Am J Hosp Pharm 1985; 42: 1557-1561.
31. Grymonpre RE, Steele JW. The medication information line for the elderly: an 8-year cumulative analysis. Ann Pharmacother 1998; 32: 743-748.
32. Hayashi S, Mukai T, Ohno K, Hashiguchi M. Patient perspectives on provision of drug information services in Japan. Yakugaku Zasshi 2003; 123: 697-706.
33. Schwabe U, Paffrath D. (Drug Prescription Report 2007) German. Springer: Berlin, 2008; 1-36.
34. Wissenschaftliches Institut der AOK (WIdO). (GKV drug information. Analysis for Saxony) German. Bonn; March 2007. http://www.gamsi.de/ dateien/GAmSiStandardbericht_2006_12_KV98.pdf [accessed 15 May 2008].
35. Jacobi F, Wittchen HU, Hölting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34: 597-611.
36. Woo JJ. Adverse event monitoring and multivitamin-multimineral dietary supplements. Am J Clin Nutr 2007; 85: 323S-324S.
37. Shields KM, McQueen CE, Bryant PJ. National survey of dietary supplement resources at drug information centers. J Am Pharm Assoc 2004; 44: 36-40.
38. Melnyk PS, Shevchuk YM, Remillard AJ. Impact of the dial access drug information service on patient outcome. Ann Pharmacother 2000; 34: 585-592.
39. Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. BMC Clin Pharmacol 2007; 7: 9.
40. Van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008; 17: 365-371.
41. Bonelli RM, Thau K. (Noncompliance: an overview), German. Dtsch Med Wochenschr 2001; 126: 699-703.
42. Balas EA, Jaffrey F, Kuperman GJ, et al. Electronic communication with patients. Evaluation of distance medicine technology. JAMA 1997; 278: 152-159.
43. Car J, Sheikh A. Telephone consultations. Br Med J 2003; 326: 966-969.
44. Wasson J, Gaudette C, Whaley F, Sauvigne A, Baribeau P, Welch HG. Telephone care as a substitute for routine clinic follow-up. JAMA 1992; 267: 1788-1793.
45. Glintborg B, Hillestrøm PR, Olsen LH, Dalhoff KP, Poulsen HE. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients. J Clin Pharmacol 2007; 47: 1440-1449.